Supplemental material
OncoImmunology
Volume 7, 2018 - Issue 2
Open access
4,226
Views
42
CrossRef citations to date
0
Altmetric
Original Research
Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
Sebastian FelgnerDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany;Infection Biology of Salmonella, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, GermanyCorrespondence[email protected]
, Dino KocijancicDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany
, Michael FrahmDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany
, Ulrike HeiseMouse-Pathology Service Unit, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany
, Manfred RohdeCentral Facility for Microscopy, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany
, Kurt ZimmermannSymbio Gruppe GmbH & Co KG, Herborn, Lower Saxony, Germany
, Christine FalkInstitute of Transplant Immunology, Medical School Hannover, Hannover, Hessia, Germany
, Marc ErhardtInfection Biology of Salmonella, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany
https://orcid.org/0000-0001-6292-619X
Siegfried WeissDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany;Institute of Immunology, Medical School Hannover, Hannover, Lower Saxony, Germany
show all
Article: e1382791
|
Received 03 May 2017, Accepted 16 Sep 2017, Published online: 16 Oct 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.